BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8789606)

  • 1. Distribution of tripeptidyl-peptidase II in the central nervous system of rat.
    Tomkinson B; Nyberg F
    Neurochem Res; 1995 Dec; 20(12):1443-7. PubMed ID: 8789606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysosomal degradation of cholecystokinin-(29-33)-amide in mouse brain is dependent on tripeptidyl peptidase-I: implications for the degradation and storage of peptides in classical late-infantile neuronal ceroid lipofuscinosis.
    Bernardini F; Warburton MJ
    Biochem J; 2002 Sep; 366(Pt 2):521-9. PubMed ID: 12038963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tripeptidyl-peptidase II: a multi-purpose peptidase.
    Tomkinson B; Lindås AC
    Int J Biochem Cell Biol; 2005 Oct; 37(10):1933-7. PubMed ID: 16125107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunolocalization of tripeptidyl peptidase II, a cholecystokinin-inactivating enzyme, in rat brain.
    Facchinetti P; Rose C; Rostaing P; Triller A; Schwartz JC
    Neuroscience; 1999; 88(4):1225-40. PubMed ID: 10336132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and cloning of tripeptidyl peptidase II from the fruit fly, Drosophila melanogaster.
    Renn SC; Tomkinson B; Taghert PH
    J Biol Chem; 1998 Jul; 273(30):19173-82. PubMed ID: 9668104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the active site of tripeptidyl-peptidase II through studies of pH dependence of reaction kinetics.
    Eklund S; Lindås AC; Hamnevik E; Widersten M; Tomkinson B
    Biochim Biophys Acta; 2012 Apr; 1824(4):561-70. PubMed ID: 22266401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological cross-reactivity between human tripeptidyl peptidase II and fibronectin.
    Tomkinson B; Zetterqvist O
    Biochem J; 1990 Apr; 267(1):149-54. PubMed ID: 1691635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tripeptidyl peptidase-I is essential for the degradation of sulphated cholecystokinin-8 (CCK-8S) by mouse brain lysosomes.
    Warburton MJ; Bernardini F
    Neurosci Lett; 2002 Oct; 331(2):99-102. PubMed ID: 12361850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the endopeptidase activity of tripeptidyl-peptidase II.
    Eklund S; Dogan J; Jemth P; Kalbacher H; Tomkinson B
    Biochem Biophys Res Commun; 2012 Aug; 424(3):503-7. PubMed ID: 22771804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of catalytic properties of tripeptidyl peptidase I (TTP-I), a serine carboxyl lysosomal protease, and its detection in tissue extracts using selective FRET peptide substrate.
    Kondo MY; Gouvea IE; Okamoto DN; Santos JA; Souccar C; Oda K; Juliano L; Juliano MA
    Peptides; 2016 Feb; 76():80-6. PubMed ID: 26775801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleotide sequence of cDNA covering the N-terminus of human tripeptidyl peptidase II.
    Tomkinson B
    Biomed Biochim Acta; 1991; 50(4-6):727-9. PubMed ID: 1840501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rat tripeptidyl peptidase I: molecular cloning, functional expression, tissue localization and enzymatic characterization.
    Du PG; Kato S; Li YH; Maeda T; Yamane T; Yamamoto S; Fujiwara M; Yamamoto Y; Nishi K; Ohkubo I
    Biol Chem; 2001 Dec; 382(12):1715-25. PubMed ID: 11843185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tripeptidyl-peptidase II expression and activity are increased in skeletal muscle during sepsis.
    Wray CJ; Tomkinson B; Robb BW; Hasselgren PO
    Biochem Biophys Res Commun; 2002 Aug; 296(1):41-7. PubMed ID: 12147224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tripeptidyl peptidase II in haemolysates and liver homogenates of various species.
    Bålöw RM; Eriksson I
    Biochem J; 1987 Jan; 241(1):75-80. PubMed ID: 3551927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development, evaluation and application of tripeptidyl-peptidase II sequence signatures.
    Eriksson S; Gutiérrez OA; Bjerling P; Tomkinson B
    Arch Biochem Biophys; 2009 Apr; 484(1):39-45. PubMed ID: 19467630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The specificity of lysosomal tripeptidyl peptidase-I determined by its action on angiotensin-II analogues.
    Warburton MJ; Bernardini F
    FEBS Lett; 2001 Jul; 500(3):145-8. PubMed ID: 11445074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysosomal heterogeneity of dipeptidyl peptidase II active on collagen-related peptides.
    Andersen KJ; McDonald JK
    Ren Physiol Biochem; 1989; 12(1):32-40. PubMed ID: 2727382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a dehydroalanine-containing peptide as an efficient inhibitor of tripeptidyl peptidase II.
    Tomkinson B; Grehn L; Fransson B; Zetterqvist O
    Arch Biochem Biophys; 1994 Nov; 314(2):276-9. PubMed ID: 7979365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of tripeptidyl peptidase I in human tissues under normal and pathological conditions.
    Kida E; Golabek AA; Walus M; Wujek P; Kaczmarski W; Wisniewski KE
    J Neuropathol Exp Neurol; 2001 Mar; 60(3):280-92. PubMed ID: 11245212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification of two dipeptidyl aminopeptidases II from rat brain and their action on proline-containing neuropeptides.
    Mentlein R; Struckhoff G
    J Neurochem; 1989 Apr; 52(4):1284-93. PubMed ID: 2564425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.